Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?

Saved in:

Bibliographic Details
Title:	Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?
Authors:	Chatzidionysiou K; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden. aikaterini.chatzidionysiou@ki.se.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. aikaterini.chatzidionysiou@ki.se., Liapi M; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden., Tsakonas G; Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Gunnarsson I; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden., Catrina A; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
Source:	Clinical rheumatology [Clin Rheumatol] 2021 May; Vol. 40 (5), pp. 1687-1695. Date of Electronic Publication: 2020 Sep 28.
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1434-9949
DOI:	10.1007/s10067-020-05420-w